Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

Probius is a deep-tech company pioneering Quantum Electrochemical Spectroscopy (QES), a novel bioanalytical platform that bridges biology and AI by creating digital twins of biological specimens.…

Probius is a deep-tech company pioneering Quantum Electrochemical Spectroscopy (QES), a novel bioanalytical platform that bridges biology and AI by creating digital twins of biological specimens.…
Core technology: Quantum Electrochemical Spectroscopy (QES): reagent-/label-free electrochemical sensing that produces cloud-stored "digital twin" signatures of biological samples
Use cases: High-dimensional phenotypic signatures for biomarker discovery, multiplex bioanalysis, preclinical models, bioproduction QC, and decentralized/predictive healthcare
Funding snapshot: Company states ~ $11M dilutive funding plus $5M non-dilutive; press materials cite an $8M Series A (Cota Capital, 2022) and Crunchbase lists a Seed round (UCeed, 2023)
Founding & HQ: Founded 2016; headquartered in Fremont, California
Bioanalytics and high-dimensional phenotypic data generation to support biomedical research, drug development, and decentralized healthcare.
2016
Biotechnology
$8M
Described in company press materials as an $8M Series A led by Cota Capital.
undisclosed
Listed on Crunchbase as a Seed round from UCeed with the amount not publicly disclosed.
“Cota Capital is cited as the lead investor for an $8M Series A (2022). Other investors named by the company include Zoic Capital, Baidu Ventures, Stanford, Shanda Group, UCeed, Bill & Melinda Gates Foundation, and Propel(X).”
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
60,000+
Open Roles
200+
New This Week
| Company |
|---|